Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cianna Medical, a medical device company, has completed a funding round totaling more than $10 million. The funding will be used to further accelerate commercialization of the company's proprietary SAVI technology for breast cancer brachytherapy.
Subscribe to our email newsletter
Participating in the company’s second funding round were Emergent Medical Partners, Saints Capital, Mitsubishi International, and Fog City Fund plus several private individuals.
Jill Anderson, president and CEO of Cianna, said: “Our ability to raise money from knowledgeable, highly regarded investors, despite the challenging economic environment, is further evidence that SAVI is a breakthrough technology.
“Cianna’s mission is to make the benefits of breast brachytherapy available to more women. It’s gratifying to achieve this goal thanks to the strength of our technology and because of SAVI’s increasingly broad acceptance among radiation oncologists, surgeons and patients.”